Biomarkers of Fabry Nephropathy: Review and Future Perspective
Progressive nephropathy is one of the main features of Fabry disease, which largely contributes to the overall morbidity and mortality burden of the disease. Due to the lack of specific biomarkers, the heterogeneity of the disease, and unspecific symptoms, diagnosis is often delayed. Clinical presen...
Main Authors: | Tina Levstek, Bojan Vujkovac, Katarina Trebusak Podkrajsek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/9/1091 |
Similar Items
-
Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
by: Tina Levstek, et al.
Published: (2021-07-01) -
Two related Chinese Fabry disease patients with a p.N215S pathological variant who presented with nephropathy
by: Bun Sheng, et al.
Published: (2020-09-01) -
Fabry Nephropathy: An Evidence-Based Narrative Review
by: María del Pino, et al.
Published: (2018-03-01) -
The coincidence of IgA nephropathy and Fabry disease
by: Maixnerová Dita, et al.
Published: (2013-01-01) -
Kidney Transplant in Fabry Disease: A Revision of the Literature
by: Irene Capelli, et al.
Published: (2020-06-01)